These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 19501936

  • 1. Reduced hippocampal glutamate in Alzheimer disease.
    Rupsingh R, Borrie M, Smith M, Wells JL, Bartha R.
    Neurobiol Aging; 2011 May; 32(5):802-10. PubMed ID: 19501936
    [Abstract] [Full Text] [Related]

  • 2. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z, Zhao C, Yu L, Zhou W, Li K.
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [Abstract] [Full Text] [Related]

  • 3. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP.
    Neurosci Lett; 2009 Apr; 384(1-2):23-8. PubMed ID: 15905028
    [Abstract] [Full Text] [Related]

  • 4. Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.
    Penner J, Rupsingh R, Smith M, Wells JL, Borrie MJ, Bartha R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):104-10. PubMed ID: 19833161
    [Abstract] [Full Text] [Related]

  • 5. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.
    Dement Geriatr Cogn Disord; 2008 Feb 01; 26(1):15-25. PubMed ID: 18566544
    [Abstract] [Full Text] [Related]

  • 6. High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.
    Bartha R, Smith M, Rupsingh R, Rylett J, Wells JL, Borrie MJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):786-93. PubMed ID: 18252268
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR, den Hollander JA, Stewart CC, Evanochko WT, Buchthal SD, Harrell LE, Zamrini EY, Brockington JC, Marson DC.
    NMR Biomed; 2007 Dec 01; 20(8):709-16. PubMed ID: 17295394
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F, Gür O, Block W, Ende G, Frölich L, Hammen T, Wiltfang J, Kucinski T, Jahn H, Heun R, Maier W, Kölsch H, Kornhuber J, Träber F.
    Neurology; 2009 May 19; 72(20):1735-40. PubMed ID: 19451528
    [Abstract] [Full Text] [Related]

  • 11. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U, Lais C, Rochmont Adu M, Kratzsch T, Frölich L, Maurer K, Zanella FE, Lanfermann H, Pantel J.
    Psychiatry Res; 2009 Jul 15; 173(1):1-7. PubMed ID: 19427767
    [Abstract] [Full Text] [Related]

  • 12. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 15; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 13. Proton MRS in twin pairs discordant for schizophrenia.
    Lutkenhoff ES, van Erp TG, Thomas MA, Therman S, Manninen M, Huttunen MO, Kaprio J, Lönnqvist J, O'Neill J, Cannon TD.
    Mol Psychiatry; 2010 Mar 15; 15(3):308-18. PubMed ID: 18645571
    [Abstract] [Full Text] [Related]

  • 14. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
    Fayed N, Dávila J, Oliveros A, Castillo J, Medrano JJ.
    Acad Radiol; 2008 Sep 15; 15(9):1089-98. PubMed ID: 18692749
    [Abstract] [Full Text] [Related]

  • 15. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM, Heinze HJ, Kaufmann J.
    J Alzheimers Dis; 2013 Sep 15; 36(1):155-63. PubMed ID: 23579327
    [Abstract] [Full Text] [Related]

  • 16. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T, Xiao S, Li X, Ding B, Ling H, Chen K, Fang Y.
    Int Psychogeriatr; 2012 Jan 15; 24(1):19-27. PubMed ID: 21676281
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients.
    Olson BL, Holshouser BA, Britt W, Mueller C, Baqai W, Patra S, Petersen F, Kirsch WM.
    Alzheimer Dis Assoc Disord; 2008 Jan 15; 22(3):269-77. PubMed ID: 18580584
    [Abstract] [Full Text] [Related]

  • 18. Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio.
    Okada T, Sakamoto S, Nakamoto Y, Kohara N, Senda M.
    Psychiatry Res; 2007 Nov 15; 156(2):169-74. PubMed ID: 17900878
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of functional MRI markers in mild cognitive impairment.
    Zhang B, Li M, Sun ZZ, Zhu B, Yuan L, Wang Y, Xu Y.
    J Clin Neurosci; 2009 May 15; 16(5):635-41. PubMed ID: 19264490
    [Abstract] [Full Text] [Related]

  • 20. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T, Shiino A, Akiguchi I.
    Dement Geriatr Cogn Disord; 2008 May 15; 26(1):89-100. PubMed ID: 18617735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.